Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
Department of Anaesthesiology, GRN Hospital Schwetzingen, Schwetzingen, Germany.
ESC Heart Fail. 2024 Oct;11(5):2913-2923. doi: 10.1002/ehf2.14847. Epub 2024 May 26.
Combined coronary artery bypass grafting (CABG) and aortic valve replacement (AVR), and female sex are associated with increased perioperative mortality in clinical risk scores. This study investigated male-female differences in short-term outcome stratified by age groups.
All patients undergoing AVR and CABG between January 2001 and June 2021 at our institution were included. 1963 patients were grouped by decades into: 59 years and younger (n = 127), 60-69 (n = 471), 70-79 (n = 1070), and 80 years and older (n = 295). The primary end points of this study were 30 and 180 days mortality. Secondary end points were influence of preoperative risk factors and impact of sex on survival and postoperative major adverse events. Female patients showed higher 30 and 180 days mortality after combined CABG and AVR surgery (8.3% vs. 4.2%, P < 0.01; 15.8% vs. 9.4%, P < 0.01). Stratified by age groups, 30 and 180 days mortality remained significantly higher in septuagenarians (9.6% vs. 2.5%, P < 0.01; 16.3% vs. 7.7%, P < 0.01). Females were significantly older, had better preserved left ventricular function, and higher incidence of diabetes mellitus compared with male patients in this subgroup (P < 0.01; P = 0.01; P < 0.01). Additionally, females received significantly less internal mammary artery (IMA) conduits (P < 0.01). Female sex (OR: 3.33, 95% CI: [1.76-6.31]; 1.93, [1.22-3.06]), higher age (1.28, [1.13-1.45]; 1.16, [1.06-1.26]), diabetes mellitus (1.93, [1.03-3.60]; 1.70, [1.08-2.67]) and LVEF <30% (3.26, [1.48-7.17]; 2.23, [1.24-4.02]) were correlated with 30 and 180 days mortality, respectively. Upon multivariable testing, sex (1.77, [1.21-2.58]) and LVEF <30% (3.71, [2.39-5.76]) remained independent predictors for major adverse postoperative events. Infrequent use of IMA grafts was associated with increased 30 and 180 days mortality as well as adverse events (0.47, [0.25-0.87]; 0.46, [0.29-0.72]; 0.61, [0.42-0.88]).
Sex disparities in baseline characteristics may delay operative intervention in female patients. The inherent risk profiles might be responsible for outcome differences in septuagenarians.
在临床风险评分中,冠状动脉旁路移植术(CABG)和主动脉瓣置换术(AVR)联合治疗以及女性与围手术期死亡率增加相关。本研究调查了按年龄组分层的短期结果中的男女差异。
本研究纳入了 2001 年 1 月至 2021 年 6 月期间在我院接受 AVR 和 CABG 的所有患者。1963 名患者按十年分为:59 岁及以下(n=127)、60-69 岁(n=471)、70-79 岁(n=1070)和 80 岁及以上(n=295)。本研究的主要终点为术后 30 天和 180 天死亡率。次要终点为术前危险因素的影响以及性别对生存和术后主要不良事件的影响。接受联合 CABG 和 AVR 手术后,女性患者 30 天和 180 天死亡率较高(8.3% vs. 4.2%,P<0.01;15.8% vs. 9.4%,P<0.01)。按年龄组分层,70 岁以上患者的 30 天和 180 天死亡率仍显著较高(9.6% vs. 2.5%,P<0.01;16.3% vs. 7.7%,P<0.01)。与男性患者相比,该亚组中的女性患者年龄明显更大,左心室功能保存更好,糖尿病发病率更高(P<0.01;P=0.01;P<0.01)。此外,女性患者接受的内乳动脉(IMA)移植物明显较少(P<0.01)。女性(OR:3.33,95%CI:[1.76-6.31];1.93,[1.22-3.06])、高龄(1.28,[1.13-1.45];1.16,[1.06-1.26])、糖尿病(1.93,[1.03-3.60];1.70,[1.08-2.67])和 LVEF<30%(3.26,[1.48-7.17];2.23,[1.24-4.02])与 30 天和 180 天死亡率相关。多变量检验后,性别(1.77,[1.21-2.58])和 LVEF<30%(3.71,[2.39-5.76])仍然是术后主要不良事件的独立预测因素。IMA 移植物使用不频繁与 30 天和 180 天死亡率以及不良事件相关(0.47,[0.25-0.87];0.46,[0.29-0.72];0.61,[0.42-0.88])。
基线特征中的性别差异可能会延迟女性患者的手术干预。固有风险状况可能是 70 岁以上患者结果差异的原因。